Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Colorcon
Deloitte
Accenture
Baxter
UBS
Medtronic
QuintilesIMS
Fuji

Generated: April 20, 2018

DrugPatentWatch Database Preview

Zydus Pharms Usa Company Profile

« Back to Dashboard

What is the competitive landscape for ZYDUS PHARMS USA, and when can generic versions of ZYDUS PHARMS USA drugs launch?

ZYDUS PHARMS USA has one hundred and fifty-nine approved drugs.

There is one US patent protecting ZYDUS PHARMS USA drugs. There are nine tentative approvals on ZYDUS PHARMS USA drugs.

There are two patent family members on ZYDUS PHARMS USA drugs in two countries and two hundred and thirty supplementary protection certificates in thirteen countries.

Summary for Zydus Pharms Usa
International Patents:2
US Patents:1
Tradenames:134
Ingredients:134
NDAs:159

Drugs and US Patents for Zydus Pharms Usa

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa Inc TOPIRAMATE topiramate CAPSULE, EXTENDED RELEASE;ORAL 207382-003 Nov 24, 2017 AB RX No No ➤ Sign Up ➤ Sign Up
Zydus Pharms Usa Inc TRANEXAMIC ACID tranexamic acid INJECTABLE;INJECTION 205228-001 Jul 17, 2017 AP RX No No ➤ Sign Up ➤ Sign Up
Zydus Pharms Usa ZONISAMIDE zonisamide CAPSULE;ORAL 077625-001 Oct 16, 2006 AB RX No No ➤ Sign Up ➤ Sign Up
Zydus Pharms Usa Inc CLOMIPRAMINE HYDROCHLORIDE clomipramine hydrochloride CAPSULE;ORAL 208961-003 Dec 27, 2017 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for ZYDUS PHARMS USA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03

Non-Orange Book US Patents for Zydus Pharms Usa

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,139,527 Method of preparation of pitavastatin and pharmaceutical acceptable salts thereof ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Supplementary Protection Certificates for Zydus Pharms Usa Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0040 France ➤ Sign Up PRODUCT NAME: EZETIMIBE; SIMVASTATINE; NAT. REGISTRATION NO/DATE: NL 31849 20050728; FIRST REGISTRATION: DE - 58 878 00 00 20040402
2000 00018 Denmark ➤ Sign Up PRODUCT NAME: BUPROPIONHYDROCHLORID; NAT. REG. NO/DATE: 31347 20000606; FIRST REG. NO/DATE: NL 24160 19991201
C/GB95/028 United Kingdom ➤ Sign Up PRODUCT NAME: TOPIRAMATE; REGISTERED: UK 0242/0301 19950718
2013025,C1304992 Lithuania ➤ Sign Up PRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
UBS
Teva
Medtronic
Covington
Mallinckrodt
US Army
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.